Efficacy and tolerability of using platelet‐rich plasma versus chemical peeling in periorbital hyperpigmentation

Background Various therapeutic modalities for periorbital hyperpigmentation (POH) have been proposed. Objective This study was designed to compare the efficacy and tolerability of autologous platelet‐rich plasma (PRP) and chemical peeling in POH. Subjects and methods Forty‐two patients were enrolled...

Full description

Saved in:
Bibliographic Details
Published inJournal of cosmetic dermatology Vol. 18; no. 6; pp. 1680 - 1685
Main Authors Ellabban, Noura F., Eyada, Moustafa, Nada, Hesham, Kamel, Noha
Format Journal Article
LanguageEnglish
Published England 01.12.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background Various therapeutic modalities for periorbital hyperpigmentation (POH) have been proposed. Objective This study was designed to compare the efficacy and tolerability of autologous platelet‐rich plasma (PRP) and chemical peeling in POH. Subjects and methods Forty‐two patients were enrolled in this study and randomly subdivided into two groups. Group A patients were assigned to receive four sessions of chemical peeling using trichloroacetic acid and lactic acid, while group B was assigned to patients who received four sessions of PRP injection with 2 weeks of intervals. Patients were assessed by digital photographs. The degree of improvement included four degrees from poor to excellent, and side effects were reported. Results Females constituted 38 out of 42 patients (mean age, 28.14 ± 3.47 years). There was a significant improvement in favor of chemical peeling over PRP. Good improvement occurred in 47.6% in the group A versus 4.8% in group B (P < 0.001). None of the PRP group had excellent improvement, while 38% of chemical peeling group did. Most of group A patients reported very pleased (47.6%) to excellent (38%) degree, in contrast to group B where 52.5% were just pleased (P < 0.001). Some of group A patients experienced itching (14.3%) and redness (14.3%), while in group B, they experienced pain (23.8%) and edema (14.3%) with nonsignificant difference between both groups (P = 0.07). Conclusions Both PRP and chemical peeling are effective for treatment of POH; however, chemical peeling is much more effective, tolerable, and satisfying procedure than PRP.
AbstractList Various therapeutic modalities for periorbital hyperpigmentation (POH) have been proposed. This study was designed to compare the efficacy and tolerability of autologous platelet-rich plasma (PRP) and chemical peeling in POH. Forty-two patients were enrolled in this study and randomly subdivided into two groups. Group A patients were assigned to receive four sessions of chemical peeling using trichloroacetic acid and lactic acid, while group B was assigned to patients who received four sessions of PRP injection with 2 weeks of intervals. Patients were assessed by digital photographs. The degree of improvement included four degrees from poor to excellent, and side effects were reported. Females constituted 38 out of 42 patients (mean age, 28.14 ± 3.47 years). There was a significant improvement in favor of chemical peeling over PRP. Good improvement occurred in 47.6% in the group A versus 4.8% in group B (P < 0.001). None of the PRP group had excellent improvement, while 38% of chemical peeling group did. Most of group A patients reported very pleased (47.6%) to excellent (38%) degree, in contrast to group B where 52.5% were just pleased (P < 0.001). Some of group A patients experienced itching (14.3%) and redness (14.3%), while in group B, they experienced pain (23.8%) and edema (14.3%) with nonsignificant difference between both groups (P = 0.07). Both PRP and chemical peeling are effective for treatment of POH; however, chemical peeling is much more effective, tolerable, and satisfying procedure than PRP.
Various therapeutic modalities for periorbital hyperpigmentation (POH) have been proposed.BACKGROUNDVarious therapeutic modalities for periorbital hyperpigmentation (POH) have been proposed.This study was designed to compare the efficacy and tolerability of autologous platelet-rich plasma (PRP) and chemical peeling in POH.OBJECTIVEThis study was designed to compare the efficacy and tolerability of autologous platelet-rich plasma (PRP) and chemical peeling in POH.Forty-two patients were enrolled in this study and randomly subdivided into two groups. Group A patients were assigned to receive four sessions of chemical peeling using trichloroacetic acid and lactic acid, while group B was assigned to patients who received four sessions of PRP injection with 2 weeks of intervals. Patients were assessed by digital photographs. The degree of improvement included four degrees from poor to excellent, and side effects were reported.SUBJECTS AND METHODSForty-two patients were enrolled in this study and randomly subdivided into two groups. Group A patients were assigned to receive four sessions of chemical peeling using trichloroacetic acid and lactic acid, while group B was assigned to patients who received four sessions of PRP injection with 2 weeks of intervals. Patients were assessed by digital photographs. The degree of improvement included four degrees from poor to excellent, and side effects were reported.Females constituted 38 out of 42 patients (mean age, 28.14 ± 3.47 years). There was a significant improvement in favor of chemical peeling over PRP. Good improvement occurred in 47.6% in the group A versus 4.8% in group B (P < 0.001). None of the PRP group had excellent improvement, while 38% of chemical peeling group did. Most of group A patients reported very pleased (47.6%) to excellent (38%) degree, in contrast to group B where 52.5% were just pleased (P < 0.001). Some of group A patients experienced itching (14.3%) and redness (14.3%), while in group B, they experienced pain (23.8%) and edema (14.3%) with nonsignificant difference between both groups (P = 0.07).RESULTSFemales constituted 38 out of 42 patients (mean age, 28.14 ± 3.47 years). There was a significant improvement in favor of chemical peeling over PRP. Good improvement occurred in 47.6% in the group A versus 4.8% in group B (P < 0.001). None of the PRP group had excellent improvement, while 38% of chemical peeling group did. Most of group A patients reported very pleased (47.6%) to excellent (38%) degree, in contrast to group B where 52.5% were just pleased (P < 0.001). Some of group A patients experienced itching (14.3%) and redness (14.3%), while in group B, they experienced pain (23.8%) and edema (14.3%) with nonsignificant difference between both groups (P = 0.07).Both PRP and chemical peeling are effective for treatment of POH; however, chemical peeling is much more effective, tolerable, and satisfying procedure than PRP.CONCLUSIONSBoth PRP and chemical peeling are effective for treatment of POH; however, chemical peeling is much more effective, tolerable, and satisfying procedure than PRP.
Background Various therapeutic modalities for periorbital hyperpigmentation (POH) have been proposed. Objective This study was designed to compare the efficacy and tolerability of autologous platelet‐rich plasma (PRP) and chemical peeling in POH. Subjects and methods Forty‐two patients were enrolled in this study and randomly subdivided into two groups. Group A patients were assigned to receive four sessions of chemical peeling using trichloroacetic acid and lactic acid, while group B was assigned to patients who received four sessions of PRP injection with 2 weeks of intervals. Patients were assessed by digital photographs. The degree of improvement included four degrees from poor to excellent, and side effects were reported. Results Females constituted 38 out of 42 patients (mean age, 28.14 ± 3.47 years). There was a significant improvement in favor of chemical peeling over PRP. Good improvement occurred in 47.6% in the group A versus 4.8% in group B (P < 0.001). None of the PRP group had excellent improvement, while 38% of chemical peeling group did. Most of group A patients reported very pleased (47.6%) to excellent (38%) degree, in contrast to group B where 52.5% were just pleased (P < 0.001). Some of group A patients experienced itching (14.3%) and redness (14.3%), while in group B, they experienced pain (23.8%) and edema (14.3%) with nonsignificant difference between both groups (P = 0.07). Conclusions Both PRP and chemical peeling are effective for treatment of POH; however, chemical peeling is much more effective, tolerable, and satisfying procedure than PRP.
Author Kamel, Noha
Ellabban, Noura F.
Eyada, Moustafa
Nada, Hesham
Author_xml – sequence: 1
  givenname: Noura F.
  surname: Ellabban
  fullname: Ellabban, Noura F.
  organization: Ministry of Health
– sequence: 2
  givenname: Moustafa
  surname: Eyada
  fullname: Eyada, Moustafa
  organization: Suez Canal University
– sequence: 3
  givenname: Hesham
  surname: Nada
  fullname: Nada, Hesham
  organization: Suez Canal University
– sequence: 4
  givenname: Noha
  orcidid: 0000-0002-8990-2312
  surname: Kamel
  fullname: Kamel, Noha
  email: nkamel30@yahoo.com
  organization: Suez Canal University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31021041$$D View this record in MEDLINE/PubMed
BookMark eNp9kctu1TAQhi1URC-w4QFQlgjpFE9sJydLdCg3VeoG1pYvkx5XThxspyg7HqHP2CfBh7QsEMIbz4y-_5dm_lNyNIYRCXkJ9BzKe3sTjD2Humv4E3ICvGWbGhpx9Kdm9JicpnRDKbQdiGfkmAGtgXI4IfGi751RZqnUaKscPEalnXd5qUJfzcmN19XkVUaP-f7nXXRmf-jToKpbjGlOldnjUBx8NSH6A-7GUkYXona5jPdL6SZ3PeCYVXZhfE6e9sonfPHwn5FvHy6-7j5tLq8-ft69u9wYVnd8o1FptG3D675hDUOgVljasS0XrbC8Mw3fMo26sVYg04LVWwtbYzSHFnkBz8jr1XeK4fuMKcvBJYPeqxHDnGRdg6AMeCMK-uoBnfWAVk7RDSou8vFOBaArYGJIKWIvjVu3yVE5L4HKQxTyEIX8HUWRvPlL8uj6TxhW-IfzuPyHlF-udu9XzS9uzpxE
CitedBy_id crossref_primary_10_1007_s12634_019_0092_x
crossref_primary_10_1007_s43032_021_00579_2
crossref_primary_10_1016_j_clindermatol_2021_08_007
crossref_primary_10_3390_cosmetics8020026
crossref_primary_10_25259_JCAS_95_2024
crossref_primary_10_59598_ME_2305_6045_2024_113_4_17_28
crossref_primary_10_1111_jocd_14036
crossref_primary_10_1016_j_sxmr_2020_12_004
crossref_primary_10_1055_s_0041_1725107
crossref_primary_10_1111_jocd_16548
crossref_primary_10_1111_prd_12582
crossref_primary_10_2147_CCID_S453243
crossref_primary_10_1007_s00403_020_02173_z
crossref_primary_10_1097_DSS_0000000000004372
crossref_primary_10_1155_dth_9155535
Cites_doi 10.1684/ejd.2014.2267
10.1016/j.ad.2013.12.021
10.1111/j.1524-4725.2011.02065.x
10.1016/j.bjps.2012.11.009
10.3109/14764172.2016.1157363
10.1111/jocd.12478
10.1111/jocd.12044
10.5021/ad.2018.30.5.522
10.3892/ijmm.2012.879
10.1111/jocd.12072
10.1111/dsu.12348
10.4103/0019-5154.127675
10.1111/j.1524-4725.2009.01213.x
10.1111/j.1524-4725.2011.02280.x
10.1016/j.biocel.2003.10.023
10.18282/jsd.v1.i2.29
10.5021/ad.2014.26.3.401
10.4103/0019-5154.185707
ContentType Journal Article
Copyright 2019 Wiley Periodicals, Inc.
Copyright_xml – notice: 2019 Wiley Periodicals, Inc.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1111/jocd.12964
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1473-2165
EndPage 1685
ExternalDocumentID 31021041
10_1111_jocd_12964
JOCD12964
Genre article
Randomized Controlled Trial
Journal Article
Comparative Study
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
1OC
24P
29K
31~
33P
36B
3SF
4.4
50Y
50Z
52M
52O
52T
52U
52V
52W
53G
5GY
5HH
5VS
702
7PT
7X7
8-0
8-1
8-3
8-4
8-5
8FI
8FJ
930
A01
A03
AAESR
AAEVG
AAHHS
AAKAS
AANHP
AAONW
AASGY
AAXRX
AAZKR
ABCUV
ABDBF
ABJNI
ABPVW
ABUWG
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCMX
ACCZN
ACGFS
ACMXC
ACPOU
ACRPL
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADPDF
ADXAS
ADZCM
ADZMN
AEEZP
AEGXH
AEIMD
AENEX
AEQDE
AEUQT
AFBPY
AFEBI
AFGKR
AFKRA
AFPWT
AFZJQ
AIACR
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BENPR
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
C45
CAG
CCPQU
COF
CS3
D-6
D-7
D-E
D-F
D-I
DCZOG
DPXWK
DRFUL
DRMAN
DRSTM
EAD
EAP
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F21
F5P
FEDTE
FUBAC
FYUFA
G-S
G.N
GODZA
H.X
HF~
HMCUK
HVGLF
HZ~
IHE
KBYEO
LATKE
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
MY~
N04
N05
NF~
O66
O9-
OIG
OVD
OVEED
P2P
P2W
P2X
P2Z
P4B
P4D
PIMPY
Q.N
QB0
R.K
ROL
RX1
SUPJJ
SV3
TEORI
TUS
UB1
UKHRP
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WVDHM
YFH
YUY
ZZTAW
~IA
~WT
AAYXX
AGQPQ
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
7X8
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
ID FETCH-LOGICAL-c3294-beabed7642f6363e10d5d09384575d49c6483beb6dd5e3b5328d18ccb417e4093
ISSN 1473-2130
1473-2165
IngestDate Fri Jul 11 03:29:54 EDT 2025
Thu Apr 03 06:59:03 EDT 2025
Thu Apr 24 23:06:17 EDT 2025
Tue Jul 01 02:37:29 EDT 2025
Wed Jan 22 16:38:00 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords patient satisfaction
chemical peel
periorbital hyperpigmentation
platelet-rich plasma
Language English
License 2019 Wiley Periodicals, Inc.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3294-beabed7642f6363e10d5d09384575d49c6483beb6dd5e3b5328d18ccb417e4093
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
ORCID 0000-0002-8990-2312
PMID 31021041
PQID 2215031465
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_2215031465
pubmed_primary_31021041
crossref_citationtrail_10_1111_jocd_12964
crossref_primary_10_1111_jocd_12964
wiley_primary_10_1111_jocd_12964_JOCD12964
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate December 2019
2019-12-00
2019-Dec
20191201
PublicationDateYYYYMMDD 2019-12-01
PublicationDate_xml – month: 12
  year: 2019
  text: December 2019
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Journal of cosmetic dermatology
PublicationTitleAlternate J Cosmet Dermatol
PublicationYear 2019
References 2009; 35
2018; 17
2016; 1
2014; 3
2013; 39
2013; 66
2013; 12
2004; 36
2014; 26
2014; 59
2014; 24
2014; 13
2018; 30
2012; 29
2016; 61
2015; 106
2012; 38
2011; 37
2016; 18
2016; 9
e_1_2_8_17_1
e_1_2_8_18_1
e_1_2_8_19_1
Al‐Shami SH (e_1_2_8_6_1) 2014; 3
Roberts WE (e_1_2_8_11_1) 2014; 13
e_1_2_8_13_1
e_1_2_8_14_1
e_1_2_8_15_1
e_1_2_8_16_1
e_1_2_8_2_1
e_1_2_8_5_1
e_1_2_8_4_1
e_1_2_8_7_1
Sarkar R (e_1_2_8_3_1) 2016; 9
e_1_2_8_9_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_10_1
e_1_2_8_21_1
e_1_2_8_22_1
e_1_2_8_12_1
References_xml – volume: 13
  start-page: 72
  year: 2014
  end-page: 78
  article-title: Assessment of efficacy of platelet‐rich plasma (PRP) on infraorbital dark circles and crow's feet wrinkles
  publication-title: J Cosmet Dermatol
– volume: 3
  start-page: 87
  year: 2014
  end-page: 94
  article-title: Treatment of periorbital hyperpigmentation using platelet‐rich plasma injections
  publication-title: Am J Dermatol Venereol
– volume: 106
  start-page: 104
  year: 2015
  end-page: 111
  article-title: Platelet‐rich plasma: applications in dermatology
  publication-title: Actas dermo‐sifiliograficas
– volume: 36
  start-page: 1482
  year: 2004
  end-page: 1491
  article-title: Transforming growth factor‐β1 decreases melanin synthesis via delayed extracellular signal‐regulated kinase activation
  publication-title: Int J Biochem Cell Biol
– volume: 29
  start-page: 32
  year: 2012
  end-page: 36
  article-title: Platelet‐rich plasma induces increased expression of G1 cell cycle regulators, type I collagen, and matrix metalloproteinase‐1 in human skin fibroblasts
  publication-title: Int J Mol Med
– volume: 59
  start-page: 151
  year: 2014
  end-page: 157
  article-title: Periorbital hyperpigmentation: a study of its prevalence, common causative factors and its association with personal habits and other disorders
  publication-title: Indian J Dermatol
– volume: 30
  start-page: 522
  year: 2018
  end-page: 528
  article-title: Treatments of infra‐orbital dark circles by various etiologies
  publication-title: Ann Dermatol
– volume: 38
  start-page: 623
  year: 2012
  end-page: 630
  article-title: Platelet‐rich plasma combined with fractional laser therapy for skin rejuvenation
  publication-title: Dermatol Surg
– volume: 26
  start-page: 401
  year: 2014
  end-page: 402
  article-title: Regression of melasma with platelet‐rich plasma treatment
  publication-title: Ann Dermatol
– volume: 18
  start-page: 289
  year: 2016
  end-page: 292
  article-title: Combination of microneedling and 10% trichloroacetic acid peels in the management of infraorbital dark circles
  publication-title: J Cosmet Laser Ther
– volume: 39
  start-page: 1903
  year: 2013
  end-page: 1911
  article-title: Epidermal growth factor and epidermal growth factor signaling attenuate laser‐induced melanogenesis
  publication-title: Dermatol Surg
– volume: 9
  start-page: 49
  year: 2016
  end-page: 55
  article-title: Periorbital hyperpigmentation: a comprehensive review
  publication-title: J Clin Aesthet Dermatol
– volume: 13
  start-page: 472
  year: 2014
  end-page: 482
  article-title: Periorbital hyperpigmentation: review of etiology, medical evaluation, and aesthetic treatment
  publication-title: J Drugs Dermatol
– volume: 61
  start-page: 413
  year: 2016
  end-page: 417
  article-title: A comparative study of two modalities, 4% hydroquinone versus 30% salicylic acid in periorbital hyperpigmentation and assessment of quality of life before and after treatment
  publication-title: Indian J Dermatol
– volume: 35
  start-page: 1163
  year: 2009
  end-page: 1171
  article-title: Infraorbital dark circles: definition, causes, and treatment options
  publication-title: Dermatol Surg
– volume: 66
  start-page: 301
  year: 2013
  end-page: 311
  article-title: The use of platelet‐rich plasma in plastic surgery: a systematic review
  publication-title: J Plast Reconstr Aesthet Surg
– volume: 12
  start-page: 204
  year: 2013
  end-page: 209
  article-title: Chemical peeling with trichloroacetic acid and lactic acid for infraorbital dark circles
  publication-title: J Cosmet Dermatol
– volume: 17
  start-page: 1
  year: 2018
  end-page: 8
  article-title: Evaluation of carboxytherapy and platelet‐rich plasma in treatment of periorbital hyperpigmentation: a comparative clinical trial
  publication-title: J Cosmet Dermatol
– volume: 24
  start-page: 100
  year: 2014
  end-page: 101
  article-title: Effects of platelet‐rich plasma on wrinkles and skin tone in Asian lower eyelid skin: preliminary results from a prospective, randomised, split‐face trial
  publication-title: Eur J Dermatol
– volume: 37
  start-page: 1297
  year: 2011
  end-page: 1303
  article-title: Periorbital hyperpigmentation in Asians: an epidemiologic study and a proposed classification
  publication-title: Dermatol Surg
– volume: 1
  start-page: 108
  year: 2016
  end-page: 115
  article-title: Treatment of periorbital dark circles: comparative study of chemical peeling with a combination of trichloroacetic acid and lactic acid versus carboxytherapy
  publication-title: Surg J Dermatol
– ident: e_1_2_8_9_1
  doi: 10.1684/ejd.2014.2267
– ident: e_1_2_8_7_1
  doi: 10.1016/j.ad.2013.12.021
– ident: e_1_2_8_19_1
  doi: 10.1111/j.1524-4725.2011.02065.x
– ident: e_1_2_8_8_1
  doi: 10.1016/j.bjps.2012.11.009
– ident: e_1_2_8_12_1
  doi: 10.3109/14764172.2016.1157363
– volume: 3
  start-page: 87
  year: 2014
  ident: e_1_2_8_6_1
  article-title: Treatment of periorbital hyperpigmentation using platelet‐rich plasma injections
  publication-title: Am J Dermatol Venereol
– ident: e_1_2_8_4_1
  doi: 10.1111/jocd.12478
– ident: e_1_2_8_21_1
  doi: 10.1111/jocd.12044
– volume: 13
  start-page: 472
  year: 2014
  ident: e_1_2_8_11_1
  article-title: Periorbital hyperpigmentation: review of etiology, medical evaluation, and aesthetic treatment
  publication-title: J Drugs Dermatol
– ident: e_1_2_8_10_1
  doi: 10.5021/ad.2018.30.5.522
– ident: e_1_2_8_13_1
  doi: 10.3892/ijmm.2012.879
– ident: e_1_2_8_14_1
  doi: 10.1111/jocd.12072
– ident: e_1_2_8_16_1
  doi: 10.1111/dsu.12348
– ident: e_1_2_8_20_1
  doi: 10.4103/0019-5154.127675
– ident: e_1_2_8_2_1
  doi: 10.1111/j.1524-4725.2009.01213.x
– ident: e_1_2_8_17_1
  doi: 10.1111/j.1524-4725.2011.02280.x
– ident: e_1_2_8_15_1
  doi: 10.1016/j.biocel.2003.10.023
– volume: 9
  start-page: 49
  year: 2016
  ident: e_1_2_8_3_1
  article-title: Periorbital hyperpigmentation: a comprehensive review
  publication-title: J Clin Aesthet Dermatol
– ident: e_1_2_8_5_1
  doi: 10.18282/jsd.v1.i2.29
– ident: e_1_2_8_18_1
  doi: 10.5021/ad.2014.26.3.401
– ident: e_1_2_8_22_1
  doi: 10.4103/0019-5154.185707
SSID ssj0017915
Score 2.2610526
Snippet Background Various therapeutic modalities for periorbital hyperpigmentation (POH) have been proposed. Objective This study was designed to compare the efficacy...
Various therapeutic modalities for periorbital hyperpigmentation (POH) have been proposed. This study was designed to compare the efficacy and tolerability of...
Various therapeutic modalities for periorbital hyperpigmentation (POH) have been proposed.BACKGROUNDVarious therapeutic modalities for periorbital...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1680
SubjectTerms Administration, Cutaneous
Adult
Blood Transfusion, Autologous - adverse effects
Blood Transfusion, Autologous - methods
Caustics - administration & dosage
Caustics - adverse effects
Cheek
Chemexfoliation - adverse effects
Chemexfoliation - methods
chemical peel
Female
Humans
Hyperpigmentation - diagnosis
Hyperpigmentation - therapy
Injections, Intradermal
Lactic Acid - administration & dosage
Lactic Acid - adverse effects
Male
Microinjections
Patient Satisfaction
periorbital hyperpigmentation
Photography
Platelet-Rich Plasma
Skin - diagnostic imaging
Skin - drug effects
Treatment Outcome
Trichloroacetic Acid - administration & dosage
Trichloroacetic Acid - adverse effects
Young Adult
Title Efficacy and tolerability of using platelet‐rich plasma versus chemical peeling in periorbital hyperpigmentation
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjocd.12964
https://www.ncbi.nlm.nih.gov/pubmed/31021041
https://www.proquest.com/docview/2215031465
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9owELYoK1W9VH2XvuSqvbQoCCdOQo7VblZotcAFKm5R_EgXiTwU4LD76zu2kxAKW217iYJl7MjzeTzjeSH0VdospolIrIQOuQXyv2ONYGNZSQK6BLE9SXUc92TqjRf0aukuO52i5bW027IBvzsZV_I_VIU2oKuKkv0HyjaDQgO8A33hCRSG54NoHKr8D6peu3aDzNeyNFm3tdV8p28BijUIk0AbC_jdjfq1SeO-csXYbfq8ThZQSBOVrj3Ky1VespWOkQQdtSxWv9IqPim7R5Ll-SZVsZB9odj89uCiPlQwY-aWdQp_ifeuxOFtLLToOslVFFfSHBDTqn2szFFpcyTEqfEomOY3cfuyggQtxw_DX6nvWDYx5SEG8kTbEVP-g8MSz1R-uo_151wMiLIl7w-42qg_nUWXi-vraB4u54_QmQ2Khd1FZ7OfYXjRWJ78QFe9aD6qSmmrvb-asQ-FmCPN5FDR0ZLK_Bl6WhEG_zB4eY46MnuBHk8qJ4qXqKhhgwE2uA0bnCdYwwYfwAYb2GADG1zDBlewwasMt2CDj2DzCi0uw_n52KoKb1jcsQNqMRkzKXxQTRPP8RxJhsIVw8AZURDuBQ24B3uaSeYJ4UqHuY49EmTEOaPElxQ6vkbdLM_kW-U5FzBQ4ihh6iKABsz1EmY7PpHKQMvdHvpWr2TEq6z0qjjKOmq0U1j1SK96D31p-hYmF8vJXp9rgkTAKpX9K84kADmyQbxV1Ro8mPWNoVQzjqNK3A8p6aHvmnR_mSC6mp1f6Ld3D5jqPXqy3wgfUHdb7uRHkGO37FMFvd_dSaMH
linkProvider Ovid
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Efficacy+and+tolerability+of+using+platelet-rich+plasma+versus+chemical+peeling+in+periorbital+hyperpigmentation&rft.jtitle=Journal+of+cosmetic+dermatology&rft.au=Ellabban%2C+Noura+F&rft.au=Eyada%2C+Moustafa&rft.au=Nada%2C+Hesham&rft.au=Kamel%2C+Noha&rft.date=2019-12-01&rft.issn=1473-2165&rft.eissn=1473-2165&rft.volume=18&rft.issue=6&rft.spage=1680&rft_id=info:doi/10.1111%2Fjocd.12964&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1473-2130&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1473-2130&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1473-2130&client=summon